KRAS and colorectal carcinoma: The prevalence of main driver mutations of CRC in our study was in alignment with globally published literature; however, the size of the studied cohort was limited due to the small number of patients undergoing simultaneous testing for BRAF, KRAS mutation status, as well as microsatellite stability status.